F52. EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY

BACKGROUND: Long-term efficacy and safety data from prospective studies in adolescents with schizophrenia are limited. Lurasidone is an atypical antipsychotic that has demonstrated efficacy in the treatment of schizophrenia in both adults and adolescents. The aim of the current open-label trial was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Schizophr Bull
Glavni autori: Goldman, Robert, Tocco, Michael, Pikalov, Andrei, Cucchiaro, Josephine, Deng, Ling, Loebel, Antony
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby017.583
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items